Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 3 4Phase NA 1Phase 1/2 1Phase 1 1

Status

Completed 27Terminated 18Recruiting 13Active not recruiting 8Withdrawn 5Unknown 3Suspended 1Not yet recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 24Colorectal Neoplasms 19Carcinoma, Non-Small-Cell Lung 19Neoplasms 18Recurrence 16Pancreatic Neoplasms 16Multiple Myeloma 15Prostatic Neoplasms 13Advanced Solid Tumors 12Carcinoma, Hepatocellular 11Stomach Neoplasms 10Leukemia, Myeloid, Acute 10Advanced Solid Tumor 10Ovarian Neoplasms 9Triple Negative Breast Neoplasms 8Small Cell Lung Carcinoma 7Squamous Cell Carcinoma of Head and Neck 6Neoplasm Metastasis 6Melanoma 6Lymphoma, Large B-Cell, Diffuse 6Head and Neck Neoplasms 6Glioblastoma 6Urinary Bladder Neoplasms 5Solid Tumors 5Lymphoma, B-Cell 5Lung Neoplasms 5Liver Neoplasms 5Glioma 5Uterine Cervical Neoplasms 4Lymphoma 4

Interventions

Surgical Procedures, Operative 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Not yet recruiting × Fallopian Tube Neoplasms × Clear all
NCT06602063 2025-06-27

Surgery for Relapsed Ovarian Cancer in Precision

Shanghai Gynecologic Oncology Group

Phase 1/2 Not yet recruiting
33 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡